Related references
Note: Only part of the references are listed.The Acidic Ribosomal Stalk Proteins Are Not Required for the Highly Specific Inactivation Exerted by α-Sarcin of the Eukaryotic Ribosome
Miriam Olombrada et al.
BIOCHEMISTRY (2014)
Effects of a second-generation human anti-ErbB2 ImmunoRNase on trastuzumab-resistant tumors and cardiac cells
Chiara D'Avino et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2014)
Fungal ribotoxins: Natural protein-based weapons against insects
Miriam Olombrada et al.
TOXICON (2014)
A novel role for junctional adhesion molecule-A in tumor proliferation: Modulation by an anti-JAM-A monoclonal antibody
Liliane Goetsch et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Targeted near-IR hybrid magnetic nanoparticles for in vivo cancer therapy and imaging
Dickson K. Kirui et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Monoclonal antibody-based therapies in cancer: Advances and challenges
Puja Sapra et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Antibody Therapeutics in Cancer
Mark X. Sliwkowski et al.
SCIENCE (2013)
Therapeutic targets and recent advances in protein immunotoxins
J. Madhumathi et al.
CURRENT OPINION IN MICROBIOLOGY (2012)
Production and characterization of scFvA33T1, an immunoRNase targeting colon cancer cells
Jaime Tome-Amat et al.
FEBS JOURNAL (2012)
Pharmacokinetics of engineered human monomeric and dimeric CH2 domains
Kurt R. Gehlsen et al.
MABS (2012)
Production and characterization of a colon cancer-specific immunotoxin based on the fungal ribotoxin -sarcin
Nelson Carreras-Sangra et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2012)
Application of Monoclonal Antibodies as Cancer Therapy in Solid Tumors
Rodrigo Dienstmann et al.
CURRENT CLINICAL PHARMACOLOGY (2012)
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes
Masanori Onda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Monoclonal Antibodies in the Treatment of Metastatic Colorectal Cancer: A Review
Jolien Tol et al.
CLINICAL THERAPEUTICS (2010)
Cleavage of the sarcin-ricin loop of 23S rRNA differentially affects EF-G and EF-Tu binding
Lucia Garcia-Ortega et al.
NUCLEIC ACIDS RESEARCH (2010)
The Evolving Role of Monoclonal Antibodies in Colorectal Cancer: Early Presumptions and Impact on Clinical Trial Development
Cathy Eng
ONCOLOGIST (2010)
Immune Therapy for Cancer
Michael Dougan et al.
ANNUAL REVIEW OF IMMUNOLOGY (2009)
JAM-A expression positively correlates with poor prognosis in breast cancer patients
Elaine A. McSherry et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
A33 antigen displays persistent surface expression
Margaret E. Ackerman et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
The therapeutic potential of fungal ribotoxins
Nelson Carreras-Sangra et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2008)
Immunotoxin treatment of cancer
Ira Pastan et al.
ANNUAL REVIEW OF MEDICINE (2007)
Fungal ribotoxins: molecular dissection of a family of natural killers
Javier Lacadena et al.
FEMS MICROBIOLOGY REVIEWS (2007)
In vitro and in vivo characterization of 177Lu-huA33 A radioimmunoconjugate against colorectal cancer
Ylva Almqvist et al.
NUCLEAR MEDICINE AND BIOLOGY (2006)
CEACAMs: their role in physiology and pathophysiology
Katharina Kuespert et al.
CURRENT OPINION IN CELL BIOLOGY (2006)
A phase I trial of humanized monoclonal antibody A33 in patients with colorectal carcinoma: Biodistribution, pharmacokinetics, and quantitative tumor uptake
AM Scott et al.
CLINICAL CANCER RESEARCH (2005)
Delivery of molecular medicine to solid tumors: lessons from in vivo imaging of gene expression and function
RK Jain
JOURNAL OF CONTROLLED RELEASE (2001)
Cytotoxic mechanism of the ribotoxin α-sarcin -: Induction of cell death via apoptosis
N Olmo et al.
EUROPEAN JOURNAL OF BIOCHEMISTRY (2001)
Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
AE Frankel et al.
PROTEIN ENGINEERING (2000)
Share Paper
